0      0

JL1107ES - JL1107ES: Cutaneous Toxicities with Amivantamab for Non-small Cell Lung Cancer (NSCLC) with Exon 20 Insertion Mutation (ex20ins): A Practical Guide and Best Practices for Management

‐ Nov 2, 2023 2:00pm

Shahnaz Singh-Kandah1,NP, Kaiwen Wang2,PharmD, Karen Xia3, PhD, Andy L. Johnson3,PhD,Denise D’Andrea3, MD, Lindsay Dougherty4, CRNP, DNP


You must be logged in and own this session in order to post comments.